相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K. Gupta et al.
NATURE (2019)
TLR1/2 Specific Small-Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes
Xiaohong Cen et al.
ADVANCED SCIENCE (2019)
HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy
Yonatan Ganor et al.
NATURE MICROBIOLOGY (2019)
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+individuals
Line K. Vibholm et al.
AIDS (2019)
Toll-like receptor polymorphism in host immune response to infectious diseases: A review
Suprabhat Mukherjee et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2019)
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Mansi Saxena et al.
FRONTIERS IN IMMUNOLOGY (2019)
TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremia
Gregory Q. Del Prete et al.
JCI INSIGHT (2019)
TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection
Bethany M. Henrick et al.
FRONTIERS IN IMMUNOLOGY (2019)
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
A. R. krarup et al.
MUCOSAL IMMUNOLOGY (2018)
Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus
Amanda B. Macedo et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
Eradication of HIV from Tissue Reservoirs: Challenges for the Cure
Rebecca Rose et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives
Lenny Zaffaroni et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells
Hsiao-Hsuan Kuo et al.
IMMUNITY (2018)
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
Szu-Han Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy
So-Yon Lim et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Structure-based discovery of a specific TLR1-TLR2 small molecule agonist from the ZINC drug library database
Zhipeng Chen et al.
CHEMICAL COMMUNICATIONS (2018)
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs
Liang Cheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists
Matthew D. Morin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Erica N. Borducchi et al.
NATURE (2018)
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Nataschja I. Ho et al.
FRONTIERS IN IMMUNOLOGY (2018)
Trial Watch: Toll-like receptor agonists in cancer immunotherapy
Melody Smith et al.
ONCOIMMUNOLOGY (2018)
Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
Amanda B. Macedo et al.
JCI INSIGHT (2018)
TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells
Rujuta A. Bam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV
M. A. Rochat et al.
JOURNAL OF VIROLOGY (2017)
Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses
Alice Gutjahr et al.
JOURNAL OF IMMUNOLOGY (2017)
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Angela Tsai et al.
JOURNAL OF VIROLOGY (2017)
Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells
David Alvarez-Carbonell et al.
RETROVIROLOGY (2017)
Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro
Erica C. Larson et al.
PLOS ONE (2017)
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
Line Vibholm et al.
CLINICAL INFECTIOUS DISEASES (2017)
Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape
Ross A. Pollack et al.
CELL HOST & MICROBE (2017)
Polyfunctional HIV-specific T cells in Post-Treatment Controllers
Assia Samri et al.
AIDS (2016)
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
Carolina Gutierrez et al.
AIDS (2016)
A Drug-Free Zone-Lymph Nodes as a Safe Haven for HIV
Anna Licht et al.
CELL HOST & MICROBE (2016)
Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication
Biju Bhargavan et al.
CELLULAR SIGNALLING (2016)
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells
Rasmus Offersen et al.
JOURNAL OF VIROLOGY (2016)
HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads
Susanna L. Lamers et al.
JOURNAL OF VIROLOGY (2016)
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
Erica N. Borducchi et al.
NATURE (2016)
Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells
Shu Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
HIV-1 Eracication: Early Trials (and Tribulations)
Adam M. Spivak et al.
TRENDS IN MOLECULAR MEDICINE (2016)
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
R. Brad Jones et al.
PLOS PATHOGENS (2016)
Molecular Determinants of GS-9620-Dependent TLR7 Activation
Indrani Rebbapragada et al.
PLOS ONE (2016)
Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases
C. Skevaki et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: From bench to bedside
Burghardt Wittig et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
Stephan Menne et al.
JOURNAL OF HEPATOLOGY (2015)
Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1
Tobias Hilbert et al.
MEDIATORS OF INFLAMMATION (2015)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S. Sogaard et al.
PLOS PATHOGENS (2015)
DAMPs from cell death to new life
Emilie Venereau et al.
FRONTIERS IN IMMUNOLOGY (2015)
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
Julian H. Elliott et al.
LANCET HIV (2015)
Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
Kui Cheng et al.
SCIENCE ADVANCES (2015)
Combined ART started during acute HIV infection protects central memory CD4+T cells and can induce remission
Antoine Cheret et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
Adam M. Spivak et al.
CLINICAL INFECTIOUS DISEASES (2014)
X-Chromosome Complement and Estrogen Receptor Signaling Independently Contribute to the Enhanced TLR7-Mediated IFN-α Production of Plasmacytoid Dendritic Cells from Women
Sophie Laffont et al.
JOURNAL OF IMMUNOLOGY (2014)
HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat
Nancy M. Archin et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Human TLR10 is an anti-inflammatory pattern-recognition receptor
Marije Oosting et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Immunologic strategies for HIV-1 remission and eradication
Dan H. Barouch et al.
SCIENCE (2014)
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H. Elliott et al.
PLOS PATHOGENS (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen et al.
LANCET HIV (2014)
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
Deana N. Toussi et al.
VACCINES (2014)
Safety, pharmacokinetics and pharmacodynamics of GS-9620, an oral Toll-like receptor 7 agonist
Uri Lopatin et al.
ANTIVIRAL THERAPY (2013)
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya-Chi Ho et al.
CELL (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
The Distribution of HIV DNA and RNA in Cell Subsets Differs in Gut and Blood of HIV-Positive Patients on ART: Implications for Viral Persistence
Steven A. Yukl et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Administration of a Toll-Like Receptor 9 Agonist Decreases the Proviral Reservoir in Virologically Suppressed HIV-Infected Patients
Anni A. Winckelmann et al.
PLOS ONE (2013)
Reactivation of latent HIV-1 in central memory CD4+ T cells through TLR-1/2 stimulation
Camille L. Novis et al.
RETROVIROLOGY (2013)
HIV-1 transcription and latency: an update
Carine Van Lint et al.
RETROVIROLOGY (2013)
Comparison of HDAC inhibitors in clinical development Effect on HIV production in latently infected cells and T-cell activation
Thomas Aagaard Rasmussen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
Targeting Toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases
Athina Savva et al.
FRONTIERS IN IMMUNOLOGY (2013)
Trial Watch Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study
J. P. Routy et al.
HIV MEDICINE (2012)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan et al.
IMMUNITY (2012)
Antiviral applications of Toll-like receptor agonists
Nigel J. Horscroft et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Proline-Proline-Glutamic Acid (PPE) Protein Rv1168c of Mycobacterium tuberculosis Augments Transcription from HIV-1 Long Terminal Repeat Promoter
Khalid Hussain Bhat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Latent HIV-1 Infection Occurs in Multiple Subsets of Hematopoietic Progenitor Cells and Is Reversed by NF-κB Activation
Lucy A. McNamara et al.
JOURNAL OF VIROLOGY (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Modulating immunity as a therapy for bacterial infections
Robert E. W. Hancock et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Structural Basis of TLR5-Flagellin Recognition and Signaling
Sung-il Yoon et al.
SCIENCE (2012)
Trial Watch Experimental Toll-like receptor agonists for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV
J. F. Bergmann et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
IRF7: activation, regulation, modification and function
S. Ning et al.
GENES AND IMMUNITY (2011)
Pathogen Recognition by the Innate Immune System
Himanshu Kumar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
A TLR5 Agonist Inhibits Acute Renal Ischemic Failure
Nobuyuki Fukuzawa et al.
JOURNAL OF IMMUNOLOGY (2011)
Structure-Activity Relationships in Toll-Like Receptor 2-Agonists Leading to Simplified Monoacyl Lipopeptides
Geetanjali Agnihotri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota
June L. Round et al.
SCIENCE (2011)
Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice
Ying Liu et al.
VACCINE (2011)
Pneumococcal conjugate vaccination in persons with HIV: the effect of highly active antiretroviral therapy
Ole S. Sogaard et al.
AIDS (2010)
Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
Laurent Hocqueloux et al.
AIDS (2010)
HIV-1 Reactivation Induced by the Periodontal Pathogens Fusobacterium nucleatum and Porphyromonas gingivalis Involves Toll- Like Receptor 4 and 9 Activation in Monocytes/Macrophages
Octavio A. Gonzalez et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Identification of Novel Synthetic Toll-like Receptor 2 Agonists by High Throughput Screening
Yue Guan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075
Stefani Spranger et al.
JOURNAL OF IMMUNOLOGY (2010)
Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling
Yue Guan et al.
JOURNAL OF IMMUNOLOGY (2010)
Flagellin as an Adjuvant: Cellular Mechanisms and Potential
Steven B. Mizel et al.
JOURNAL OF IMMUNOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+Cell Infection
Nancie M. Archin et al.
PLOS ONE (2010)
Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
Jin Young Kang et al.
IMMUNITY (2009)
MyD88 Adapter-like (Mal)/TIRAP Interaction with TRAF6 Is Critical for TLR2-and TLR4-mediated NF-κB Proinflammatory Responses
Brett Verstak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1
Angela Meier et al.
NATURE MEDICINE (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7
Tomoko Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CL097, A TLR7/8 LIGAND, INHIBITS TLR-4-DEPENDENT ACTIVATION OF IRAK-M AND BCL-3 EXPRESSION
Branka Petricevic et al.
SHOCK (2009)
TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4(+) T cells
Sandra Thibault et al.
VIROLOGY (2009)
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
Nancy M. Archin et al.
AIDS (2008)
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Nathalie Sagot-Lerolle et al.
AIDS (2008)
Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-Mediated differential signaling
Behnam Naderi Kalali et al.
JOURNAL OF IMMUNOLOGY (2008)
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta
Jonathan C. Kagan et al.
NATURE IMMUNOLOGY (2008)
Anti-HIV Activity Mediated by Natural Killer and CD8+Cells after Toll-Like Receptor 7/8 Triggering
Erika Schlaepfer et al.
PLOS ONE (2008)
An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models
Lyudmila G. Burdelya et al.
SCIENCE (2008)
Synthetic agonists of Toll-like receptors 7, 8 and 9
S. Agrawal et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Failure of TLR4-driven NF-κB activation to stimulate virus replication in models of HIV type 1 activation
Sushila K. Nordone et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART
Liliana Belmonte et al.
AIDS (2007)
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide
Mi Sun Jin et al.
CELL (2007)
NK cell lysis of HIV-1-infected autologous CD4 primary T cells: Requirement for IFN-mediated NK activation by plasmacytoid dendritic cells
Costin Tomescu et al.
JOURNAL OF IMMUNOLOGY (2007)
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid
Janet D. Siliciano et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
Xinmei Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Discovery of ANA975: An oral prodrug of the TLR-7 agonist isatoribine
Alan X. Xiang et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2007)
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Lydie Trautmann et al.
NATURE MEDICINE (2006)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day et al.
NATURE (2006)
TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection
Erika Schlaepfer et al.
JOURNAL OF IMMUNOLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
H Häcker et al.
NATURE (2006)
The low-toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells
BS Thompson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman et al.
LANCET (2005)
Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses
U Wille-Reece et al.
JOURNAL OF IMMUNOLOGY (2005)
Mammalian Toll-like receptors: to immunity and beyond
PA Hopkins et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Synthetic TLR Agonists reveal functional differences between human TLR7 and TLR8
KB Gorden et al.
JOURNAL OF IMMUNOLOGY (2005)
Toll-like receptor 6-independent signaling by diacylated lipopeptides
U Buwitt-Beckmann et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Signaling through toll-like receptors triggers HIV-1 replication in latently infected mast cells
JB Sundstrom et al.
JOURNAL OF IMMUNOLOGY (2004)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Cutting edge:: Activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma
V Redecke et al.
JOURNAL OF IMMUNOLOGY (2004)
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis
JM Brenchley et al.
JOURNAL OF VIROLOGY (2004)
TIR domain-containing adaptors define the specificity of TLR signaling
M Yamamoto et al.
MOLECULAR IMMUNOLOGY (2004)
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
J Vollmer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells
C Scheller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Polyriboinosinic polyribocytidylic acid [poly(I : C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8(+) cytotoxic T lymphocytes
C Fujimoto et al.
INTERNATIONAL IMMUNOLOGY (2004)
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses
K Loré et al.
JOURNAL OF IMMUNOLOGY (2003)
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway
M Yamamoto et al.
SCIENCE (2003)
Cutting edge:: In vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on toll-like receptor 2
A Báfica et al.
JOURNAL OF IMMUNOLOGY (2003)
Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7
J Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells:: Implications of simultaneous activation of TLRs on HIV replication
O Equils et al.
JOURNAL OF IMMUNOLOGY (2003)
Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2
BN Gantner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
A Jordan et al.
EMBO JOURNAL (2003)
TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway
M Yamamoto et al.
NATURE IMMUNOLOGY (2003)
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4
M Yamamoto et al.
NATURE (2002)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Toll-like receptors: critical proteins linking innate and acquired immunity
S Akira et al.
NATURE IMMUNOLOGY (2001)
Discrimination of bacterial lipoproteins by Toll-like receptor 6
O Takeuchi et al.
INTERNATIONAL IMMUNOLOGY (2001)
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
F Hayashi et al.
NATURE (2001)
Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells
TH Chuang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
Bacterial lipopolysaccharide activates HIV long terminal repeat through toll-like receptor 4
O Equils et al.
JOURNAL OF IMMUNOLOGY (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
A Ozinsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88
M Schnare et al.
CURRENT BIOLOGY (2000)
分享论文
